Olfr846, also referred to as OrX, represents an essential player within the complex realm of the olfactory system in Mus musculus (house mouse). This specific olfactory receptor serves as a crucial molecular sentinel, stationed in the nasal epithelium, ready to fulfill its distinctive role in scent recognition. Olfr846 belongs to the extensive family of olfactory receptors, each sharing a fundamental structural foundation characterized by a seven-transmembrane domain structure, a common feature among G-protein-coupled receptors (GPCRs). Such structural similarity underscores its pivotal function in signal transduction within the olfactory system. The primary responsibility of Olfr846 lies in the recognition of odorant molecules present in the mouse's environment. This receptor stands as a molecular gateway, poised to respond to the presence of specific odorants. When an odorant molecule interacts with Olfr846, a cascade of intricate intracellular events is initiated, ultimately leading to the perception of distinct odors. Within the genome, the olfactory receptor gene family in mice ranks among the most expansive, with nomenclature uniquely designated for olfactory receptor genes and proteins within this organism. Olfr846 is one of the many olfactory receptors, each with its unique set of ligand-binding properties. The role it plays in the mouse's sensory experience is vital, as it facilitates the mouse's ability to navigate its environment, distinguish between food sources and threats, and engage with its surroundings through the recognition of scent cues.
Inhibition of Olfr846 presents a multifaceted challenge, especially given the absence of specific direct inhibitors designed for this receptor. Consequently, indirect inhibition strategies emerge as potential avenues for modulating Olfr846 activity. These indirect approaches typically involve the manipulation of cellular pathways and processes that are interconnected with Olfr846's function. For instance, the modulation of the PI3K/AKT pathway through specific inhibitors can lead to indirect Olfr846 inhibition by affecting AKT phosphorylation, an event intricately tied to olfactory signal transduction. Similarly, compounds targeting the p38 MAPK pathway may indirectly influence Olfr846 by altering downstream signaling events related to olfaction. Additionally, the inhibition of the ERK/MAPK pathway can potentially suppress Olfr846 expression by blocking ERK phosphorylation, thus affecting its role in signal transduction. These indirect mechanisms of inhibition highlight the complexity of olfactory receptor regulation and emphasize the need to consider the broader cellular context in which Olfr846 functions. In conclusion, Olfr846 assumes a pivotal role within the olfactory system of Mus musculus, serving as a molecular sentinel that enables the perception of diverse odors.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol influences the SIRT1 pathway, potentially indirectly affecting Olfr846. It activates SIRT1, which may modulate downstream signaling cascades related to olfaction. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 targets the PI3K/AKT pathway, which could indirectly impact Olfr846 expression by inhibiting AKT phosphorylation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 affects the p38 MAPK pathway, potentially influencing Olfr846 through downstream signaling alterations. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits the ERK/MAPK pathway, which may indirectly suppress Olfr846 expression by blocking ERK phosphorylation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin targets PI3K, potentially affecting Olfr846 by modulating the PI3K/AKT pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which could indirectly lead to reduced Olfr846 expression through the mTOR signaling pathway. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin influences the NF-κB pathway, potentially affecting Olfr846 by reducing NF-κB activity and its downstream effects. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $38.00 $79.00 $188.00 $520.00 $1248.00 $5930.00 | 8 | |
Niclosamide targets Wnt/β-catenin signaling, which may indirectly impact Olfr846 by modulating the Wnt pathway. | ||||||
NFκB Activation Inhibitor II, JSH-23 | 749886-87-1 | sc-222061 sc-222061C sc-222061A sc-222061B | 5 mg 10 mg 50 mg 100 mg | $214.00 $257.00 $1775.00 $2003.00 | 34 | |
JSH-23 targets the NF-κB pathway, which could indirectly affect Olfr846 by reducing NF-κB activity and downstream effects. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 modulates the TGF-β pathway, potentially impacting Olfr846 expression through downstream signaling alterations. | ||||||